Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Bergan

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Nutrition and Cancer|April 30, 2019
Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR CellsYongjun Li, Yukai Guo, Zhuang Feng, et al.
ACS Chemical Biology|March 7, 2017
A Chemical Probe Strategy for Interrogating Inhibitor Selectivity Across the MEK Kinase FamilyKristine K Deibler, Rama K Mishra, Matthew R Clutter, et al.
Clinical Breast Cancer|June 3, 2020
A Randomized Parallel Controlled Phase II Trial of Recombinant Human Endostatin Added to Neoadjuvant Chemotherapy for Stage III Breast CancerXiangmei Zhang, Zhenzhen Zhang, Miao Cao, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 21, 2025
KBU2046 exerts inhibition on chemokine gradient-mediated motility of esophageal squamous cell carcinoma through reducing integrin expressionKexin Li, Jinxia Chen, Wendi Li, et al.
Clinical Trials (London, England)|January 17, 2013
Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trialAlexander Dew, Seema Khan, Christie Babinski, et al.
Journal of Chemical Information and Modeling|October 1, 2019
Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential ChargesRama K Mishra, Kristine K Deibler, Matthew R Clutter, et al.
Cancer Investigation|October 24, 2007
A phase II study of single agent bortezomib in patients with metastatic breast cancer: a single institution experienceRyan H Engel, Jennifer A Brown, Jamie H Von Roenn, et al.
Cancers|September 28, 2024
Protein Structure Inspired Discovery of a Novel Inducer of Anoikis in Human MelanomaFangfang Qiao, Thomas Andrew Binkowski, Irene Broughan, et al.
Oncotarget|April 17, 2017
Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete menJames R Marshall, Raymond F Burk, Rochelle Payne Ondracek, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Protein Structure Inspired Drug DiscoveryFangfang Qiao, T Andrew Binknowski, Irene Broughan, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Nutrition and Cancer|April 30, 2019
Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR CellsYongjun Li, Yukai Guo, Zhuang Feng, et al.
ACS Chemical Biology|March 7, 2017
A Chemical Probe Strategy for Interrogating Inhibitor Selectivity Across the MEK Kinase FamilyKristine K Deibler, Rama K Mishra, Matthew R Clutter, et al.
Clinical Breast Cancer|June 3, 2020
A Randomized Parallel Controlled Phase II Trial of Recombinant Human Endostatin Added to Neoadjuvant Chemotherapy for Stage III Breast CancerXiangmei Zhang, Zhenzhen Zhang, Miao Cao, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 21, 2025
KBU2046 exerts inhibition on chemokine gradient-mediated motility of esophageal squamous cell carcinoma through reducing integrin expressionKexin Li, Jinxia Chen, Wendi Li, et al.
Clinical Trials (London, England)|January 17, 2013
Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trialAlexander Dew, Seema Khan, Christie Babinski, et al.
Journal of Chemical Information and Modeling|October 1, 2019
Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential ChargesRama K Mishra, Kristine K Deibler, Matthew R Clutter, et al.
Cancer Investigation|October 24, 2007
A phase II study of single agent bortezomib in patients with metastatic breast cancer: a single institution experienceRyan H Engel, Jennifer A Brown, Jamie H Von Roenn, et al.
Cancers|September 28, 2024
Protein Structure Inspired Discovery of a Novel Inducer of Anoikis in Human MelanomaFangfang Qiao, Thomas Andrew Binkowski, Irene Broughan, et al.
Oncotarget|April 17, 2017
Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete menJames R Marshall, Raymond F Burk, Rochelle Payne Ondracek, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Protein Structure Inspired Drug DiscoveryFangfang Qiao, T Andrew Binknowski, Irene Broughan, et al.
Pageof 4